DALLAS--(BUSINESS WIRE)--Lantern Pharma Inc., (NASDAQ: LTRN), an artificial intelligence (“AI”) company developing targeted and transformative cancer therapies using its proprietary RADR ® AI and ...
As of 1 April 2022, the European Patent Office (EPO) has changed its policy regarding the issuance of electronic certificates of grant for European patents. If the patent proprietor or their ...
Propanc Biopharma, Inc. (OTC Pink: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company developing novel cancer treatments for patients suffering from recurring and metastatic cancer, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results